30th week of 2016 patent applcation highlights part 8 |
Patent application number | Title | Published |
20160213632 | Memory Performance and Prevention and Treatment of Neurodegenerative Diseases | 2016-07-28 |
20160213633 | METHOD OF INDUCING ANTI-GLATIRAMER ACETATE ANTIBODY RESPONSE | 2016-07-28 |
20160213634 | CARCINOMA DIAGNOSIS AND TREATMENT, BASED ON ODC1 GENOTYPE | 2016-07-28 |
20160213635 | COMPOSITIONS USEFUL IN THE PREVENTION OR TREATMENT OF SKIN CANCER | 2016-07-28 |
20160213636 | STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME | 2016-07-28 |
20160213637 | Use of Glyceryl Trinitrate for Treating Traumatic Edema | 2016-07-28 |
20160213638 | POLYENOLIC ZINC-BINDING AGENTS (PEZBINS) ACTIVELY PROMOTE INACTIVATION OF CANCER STEM CELLS AND POTENTIATE CYTOTOXIC ANTI-TUMOR DRUG SUBSTANCES | 2016-07-28 |
20160213639 | COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | 2016-07-28 |
20160213640 | ANTICANCER AGENT COMPRISING AMINOACETONITRILE COMPOUND AS ACTIVE INGREDIENT | 2016-07-28 |
20160213641 | Compositions and Methods for Improving Mitochondrial Function and Treating Neurodegenerative Diseases and Cognitive Disorders | 2016-07-28 |
20160213642 | NUTRACEUTICAL COMPOSITION FOR PDE4 INHIBITION, ENHANCED DOPAMINE METABOLISM AND LONG TERM POTENTIATION | 2016-07-28 |
20160213643 | Compositions and Methods for Improving Mitochondrial Function and Treating Neurodegenerative Diseases and Cognitive Disorders | 2016-07-28 |
20160213644 | Regulation of Body Weight Gain By Using Dibenzo-Alpha-Pyrones | 2016-07-28 |
20160213645 | COMBINATION OF LEVETIRACETAM AND A BETA-SECRETASE (BACE) INHIBITOR | 2016-07-28 |
20160213646 | NEW USE | 2016-07-28 |
20160213647 | COMPOSITIONS AND METHODS FOR INHIBITING VIRAL INFECTION | 2016-07-28 |
20160213648 | Tetrazolones as a Carboxylic Acid Bioisosteres | 2016-07-28 |
20160213649 | Compositions And Methods Of Treatment Of Inflammatory Skin Conditions Using Allantoin | 2016-07-28 |
20160213651 | PIDOTIMOD FOR USE IN THE TREATMENT OF INFLAMMATION-ASSOCIATED DISEASES | 2016-07-28 |
20160213652 | Cyclic Ether Pyrazol-4-YL-Heterocyclyl-Carboxamide Compounds And Methods Of Use | 2016-07-28 |
20160213653 | HETEROCYCLIC ITK INHIBITORS FOR TREATING INFLAMMATION AND CANCER | 2016-07-28 |
20160213654 | BICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS | 2016-07-28 |
20160213655 | 1,6- DIAZABICYCLO [3,2,1] OCTAN- 7- ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | 2016-07-28 |
20160213656 | HYOSCYAMINE DOSAGE FORM | 2016-07-28 |
20160213657 | PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF PULMONARY DISEASE | 2016-07-28 |
20160213658 | PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST AND PROCESS FOR PREPARATION THEREOF | 2016-07-28 |
20160213659 | TREATMENT OF BURN PAIN BY TRPV1 MODULATORS | 2016-07-28 |
20160213660 | PHENYL DERIVATIVE | 2016-07-28 |
20160213661 | Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions | 2016-07-28 |
20160213662 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | 2016-07-28 |
20160213663 | TREATMENT OF LUPUS ARTHRITIS USING LAQUINIMOD | 2016-07-28 |
20160213664 | TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS AND CEREBRAL ANEURYSMS WITH RHO KINASE INHIBITORS | 2016-07-28 |
20160213665 | SOLUTION FOR ORAL ADMINISTRATION | 2016-07-28 |
20160213666 | NOVEL COMPOUND USEFUL FOR THE TREATEMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES | 2016-07-28 |
20160213667 | COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL DISEASES | 2016-07-28 |
20160213668 | Compounds for use in Treatment of Mucostis | 2016-07-28 |
20160213669 | USE OF N-(4-((3-(2-AMINO-4-PYRIMIDINYL)-2-PYRIDINYL)OXY)PHENYL)-4-(4-METHY- L-2-THIENYL)-1-PHTHALAZINAMINE IN COMBINATION WITH HISTONE DEACETYLASE INHIBITORS FOR TREATMENT OF CANCER | 2016-07-28 |
20160213670 | BICYCLIC HETEROARYL CYCLOALKYLDIAMINE DERIVATIVES AS INHIBITORS OF SPLEEN TYROSINE KINASES (SYK) | 2016-07-28 |
20160213671 | PROPHYLAXIS AND TREATMENT OF A NEURODEGENERATIVE DISEASE NOT BASED ON A PROTEIN-FOLDING DISORDER | 2016-07-28 |
20160213672 | Combination | 2016-07-28 |
20160213673 | ENDURANCE FORMULATION AND USE | 2016-07-28 |
20160213674 | PDE9 Inhibitors with Imidazo Triazinone Backbone | 2016-07-28 |
20160213675 | Triazine Compounds and Compositions Thereof and Methods for Treating Malaria and Chemoprophylaxis | 2016-07-28 |
20160213676 | Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor Antagonists for Treating Multiple Sclerosis | 2016-07-28 |
20160213677 | NEW COMPOUNDS | 2016-07-28 |
20160213678 | OREXIN RECEPTOR ANTAGONISTS | 2016-07-28 |
20160213679 | INHIBITORS OF POLYNUCLEOTIDE REPEAT-ASSOCIATED RNA FOCI AND USES THEREOF | 2016-07-28 |
20160213681 | DOSAGE FORMS CONTAINING FLUTICASONE PROPIONATE FOR THE TREATMENT OF INFLAMMATORY CONDITIONS OF THE ESOPHAGUS | 2016-07-28 |
20160213682 | FULVESTRANT COMPOSITIONS | 2016-07-28 |
20160213684 | SOLID DISPERSION OF A SELECTIVE MODULATOR OF THE PROGESTERONE RECEPTOR | 2016-07-28 |
20160213685 | NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS ANDTHERAPIES | 2016-07-28 |
20160213686 | 17-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODS | 2016-07-28 |
20160213687 | PROGESTERONE CONTAINING ORAL DOSAGE FORMS AND KITS | 2016-07-28 |
20160213688 | INHALABLE MEDICAMENT | 2016-07-28 |
20160213689 | Treatment of Pulmonary Disease | 2016-07-28 |
20160213690 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISEASES | 2016-07-28 |
20160213691 | Treating Various Disorders Using TrkB Agonists | 2016-07-28 |
20160213692 | ADVANCED METHOD OF TREATMENT AND MANAGEMENT OF CHRONIC HEPATITIS C INFECTION | 2016-07-28 |
20160213693 | TREATMENT AND/OR PREVENTION OF BONE METASTASIS | 2016-07-28 |
20160213694 | FORMULATIONS AND METHODS FOR TREATMENT OF METABOLIC SYNDROME | 2016-07-28 |
20160213695 | PHOSPHAPLATINS AS NEUROPROTECTIVE AGENTS | 2016-07-28 |
20160213696 | TREATMENT OF CYR61- AND VEGF-MEDIATED CONDITIONS | 2016-07-28 |
20160213697 | USE OF LACTULOSE IN THE TREATMENT OF AUTISM | 2016-07-28 |
20160213698 | COMPOSITIONS COMPRISING RUTIN USEFUL FOR THE TREATMENT OF TUMORS RESISTANT TO CHEMOTHERAPY | 2016-07-28 |
20160213699 | RUTIN-RICH EXTRACT AND METHOD OF MAKING SAME | 2016-07-28 |
20160213700 | TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) | 2016-07-28 |
20160213701 | METHODS AND COMPOSITIONS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES | 2016-07-28 |
20160213702 | GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF | 2016-07-28 |
20160213703 | METHOD FOR TREATMENT OF PULMONARY FIBROSIS | 2016-07-28 |
20160213704 | Advanced functional biocompatible polymeric matrix containing nano-compartments | 2016-07-28 |
20160213705 | METHOD TO TREAT ONYCHOMYCOSIS BY HYDROXYPROPYL CHITOSAN | 2016-07-28 |
20160213706 | TREATMENT OF MYELOSUPPRESSION | 2016-07-28 |
20160213707 | CATIONIC POLYAMINES FOR TREATMENT OF VIRUSES | 2016-07-28 |
20160213708 | OPHTHALMIC COMPOSITION | 2016-07-28 |
20160213709 | Universal Healing Tonic for Arthritis & Pain | 2016-07-28 |
20160213710 | MAGNESIUM BATH SALT | 2016-07-28 |
20160213711 | Cancer Therapy With Silver Nanoparticles | 2016-07-28 |
20160213712 | TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING NANONIZED SILVER SULFADIAZINE | 2016-07-28 |
20160213713 | MINERAL PITCH RESIN MANUFACTURED UNDER A SAFE AND LOW TEMPERATURE PROCEDURE | 2016-07-28 |
20160213714 | INDUCTION OF CELLULAR SENESCENCE FOR TISSUE THERAPIES | 2016-07-28 |
20160213715 | Cancer Immunotherapy | 2016-07-28 |
20160213716 | Bone Augmentation Utilizing Muscle-Derived Progenitor Compositions, And Treatments Thereof | 2016-07-28 |
20160213717 | COMPOSITIONS AND METHODS FOR GENERATION OF HUMAN EPITHELIAL STEM CELLS | 2016-07-28 |
20160213718 | A Probiotic Composition Comprising The Novel Isolated Bacterial Strain of Brevibacterium casei AP9 | 2016-07-28 |
20160213719 | ANTIVIRAL AGENT | 2016-07-28 |
20160213720 | PROCESS FOR THE EXTRACTION OF CANNABINOIDS FROM CANNABIS USING LIPIDS AS AN EXTRACTION SOLVENT | 2016-07-28 |
20160213721 | COCOA POLYPHENOLS AND THEIR USE IN THE TREATMENT OR PREVENTION OF EOSINOPHILIC ESOPHAGITIS | 2016-07-28 |
20160213722 | EXTRACTION DEVICES, SYSTEMS, AND METHODS | 2016-07-28 |
20160213723 | COMPOSITION FOR PREVENTING AND TREATING CANCER-RELATED FATIGUE, CONTAINING PROCESSED GINSENG POWDER OR PROCESSED GINSENG EXTRACT HAVING INCREASED GINSENOSIDE CONSTITUENT | 2016-07-28 |
20160213724 | AQUEOUS PLANT EXTRACTS | 2016-07-28 |
20160213725 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING THYROID DISEASES, CONTAINING LONICERA CAERULEA L. VAR. EDULIS FRUIT EXTRACT AS ACTIVE INGREDIENT | 2016-07-28 |
20160213726 | MEDICINAL PLANT EXTRACT | 2016-07-28 |
20160213727 | Methods and Uses of High Thymoquinone and Thymohydroquinone Essential Oil of Monarda | 2016-07-28 |
20160213728 | DIETARY SUPPLEMENTS FOR TREATING ADHD AND RELATED DISORDERS | 2016-07-28 |
20160213729 | FILIPENDULA VULGARIS EXTRACT AND USES THEREOF | 2016-07-28 |
20160213730 | IDENTIFICATION OF NATURAL PLANT EXTRACTS HARBORING ANTI-HEPATITIS C VIRUS NS5B POLYMERASE ACTIVITY | 2016-07-28 |
20160213731 | COMPOSITION COMPRISING FERMENTED TEA EXTRACTS FOR REDUCING LIPID LEVEL | 2016-07-28 |
20160213732 | PILLOW USING ACORUS GRAMINEUS AND METHOD FOR MANUFACTURING SAME | 2016-07-28 |
20160213733 | CHARACTERIZATION OF RICE | 2016-07-28 |
20160213734 | PROCESS FOR MANUFACTURING GLATIRAMER ACETATE PRODUCT | 2016-07-28 |